prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, F. 1. Pathologic Interpretation: A. Lymph node, sentinel lymph node, TP: No carcinoma seen in one lymph node (0/1). Keratin immunostains is pending. B. Lymph node, sentinel lymph node, TP: No carcinoma seen in one lymph node (0/1). Keratin immunostains is pending. C. Lymph node, sentinel lymph node, TP: No carcinoma seen in one lymph node (0/1). Keratin immunostains is pending. D. Right breast mass, 1 short stitch superior, 1 long stitch lateral: Infiltrating, poorly differentiated ductal carcinoma, (high nuclear grade), 1.7 cm in greatest dimension. The tumor cells are positive for ER and PR and they are negative for HER by immunohistochemestry. HER-2 CISH is pending. See tumor summary. E. Additional medial nodule, FS: Mammary parenchyma with stromal fibrosis and associated calcifications. Surgical pathology cancer case tumor summary. Specimen Type: Partial breast. Procedure: Excision with out wire-guided localization. Lymph Node Sampling: Sentinel lymph node. Specimen integrity: Single intact specimen (margins can be evaluated). Specimen size: Greatest dimension 5.8 cm/additional dimension; 538 x 2.5 cm. Laterality: Right. Tumor Site: Not specify. Tumor Size: Greatest dimension of focus of invasive 1.7 cm; additional dimension 1.6 x 1.6 cm. Tumor focality: single focus of invasive carcinoma. Macroscopic and microscopic extent of tumor: -Skin is not present. -Skeletal muscle is not present. Ductal carcinoma in situ: Ductal cell carcinoma in situ is present. Size extent of (DCIS): Numbers of blocks with (DCIS). 1 / Numbers of blocks evaluated. 8. Architectural Patterns: cribriform/solid. Nuclear grade: Grade III. Necrosis: Present, central expansive comedo. Lobular Carcinoma: Not identified. Histologic Type: Invasive ductal carcinoma (no special type or not otherwise specified). Histologic Grade:Nottingham Histologic Score: 3 (3+3+2=8). Glandular/Tubular formation: Score 3. Nuclear Pleomorphism: Score 3. Mitotic Count: Score 2. Margins: Margins uninvolved by Invasive carcinoma. Distance from closest margin: 1 mm (Anterior). Distance from superior margin> 5 mm/ Distance from inferior margin 5 mm/ Distance from anterior margin I. mm/. Distance from posterior hargin>7mm/Distance from medial margin>5 mm/ Distance from lateral margin>5 mm. Margins uninvolved by (DCIS). Distance from closest margin: 5 mm (Anterior). SURGICAL PATHOL Report. Distance from closest margin 5 mm// Distance from superior margin> 5 mm/ Distance from inferior margin 6 mm/ Distance. from anterior margin 5 mm/ Distance from posterior margin>7mm/Distance from medial margin>5 mm/ Distance from. lateral margin>5 mm. Lymph vascular Invasion: Present. Dermal lymph-vascular Invasion: No skin present. Lymph nodes: Number of sentinel lymph nodes examined 3. Tótal numbers of lymph nodes with macrometastases (>0.2 cm) Q. Number of lymph nodes with macrometastases (>0.2 mm and < 200 cells) 0. Method of evaluation of sentinel lymph nodes: Hematoxylin and eosin (H&E), one level/immunohistochemistry. pending. Pathologic Staging: Primary Tumor: pTic. Regional lymph nodes: pNO. Distant Metastasis: No applicable. Estrogen Receptor: Pending. Progesterone Receptor: Pending. HER2 IHC and CISH: Pending. Preliminary Dx: AJCC pTc1 No (sn) MX (Final AJCC pending evaluation of keratin immunosatin on sentinel/ymph. nodes). "Electronically Signed Out By. NOTE: Some immunohistochernical antibodies are analyte specific reagents (ASRs) validated by our laboratory (Her 2, Parvo, H. pylori, HBcore). These ASRs are clinically ubelut indicators that do. not require FDA approvel. These clones are used: IDS-ER, PpR 636-PR, A485=HER2, H-11=EGFR, CCH2/DOG9-CMV, F39.4. 1=AR and HPV by ISH. AI immunohistocheinica/ stains are used. mith formalin or molecular fixed, paraffin embedded tissue. Detection is by LSAB. The results are read by a pathologist as positive or negative. As the attending pathologist, / attest that I: (i) Examined the relevant. preparation(s) for the specimen(s); and (") Rendered the diagnosis(es). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. A. Lymph node, sentinel lymph node,. -Keratin negative for tumor cells. B. Lymph node, sentinel lymph node,. -Keratin negative for tumor cells. C. Lymph node, sentinel lymph node,. -Keratin negative for tumor cells. Addendum. Date Complete: SURGICAL PATHOL Report. Addendum Diagnosis. The tumor cells are positive for ER and PR and negative for HER-2 by immunohlstochemistry. HER-2 CISH is negative. Final AJCC staging pT1C NO (sn) (i-) MX. Intraoperative Consultation. AFS. Lymph node, sentinel lymph node,. I ct. Lymphocytes present. No evidence of malignancy. BFS. Lymph node, sentinel lymph node,. / ct. Lymphocytes present. No evidence of malignancy. CFS. Lymph node, sentinel lymph node,. ct. Lymphocytes present. No evidence of malignancy. EFS. Additional medial nodule, FS: fibrosis,. No malignancy seen. Clinical History: (Not Provided}. Pre Operative Diagnosis: Right breast cancer. Specimen(s) Received: A: Lymph node, sentinel lymph node,. B: Lymph node, sentinel lymph node,. C: Lymph node, sentinel lymph node,. D: Right breast mass, 1 short stitch superior, 1 long stitch lateral. E: Additional medial nodule, FS. Gross Description: A. Received fresh and labeled "lymph node, sentinel lymph node, TP #1" is a segment of fibro-adipose tissue 1.3 x 0.9 x 0.6. cm. Specimen bisected and submitted in toto in one cassette. 8. Received fresh and labeled "lymph node, sentinel lymph node, TP#2" is a segment of yellow-tan, fibro-adipose tissue, 1.2. x 0.8 x 0.6 cm. Specimen bisected and submitted in toto in one cassette. C. Received fresh and labeled "lymph node, sentinel lymph node, TP #3 is a segment of pale-tan fibro-adipose tissue, 1.8. x. 1.2 x 0.3 cm. Specimen submitted in toto in one cassette. D. Received in formalin and labeled "right breast mass, 1 short stitch superior, 1 long stitch lateral" is a lumpectomy. specimen measuring 5.8 x 5.8 x 2.5 cm and weighs 26.5 grams. Specimen oriented with one short stitch indicating. superior and one long stitch lateral. Resection margins inked as follows: Superior margin inked blue, inferior margin inked. red, lateral margin inked orange, anterior margin inked yellow, posterior (deep) inked black. Sections of the specimen. reveal and irregular shaped, ill-defined, indurate, white-tan mass, 1.7 x 1.6 x 1.6 cm. The mass is present at 0.1 cm from. the anterior margin (closest-yellow). The reminder margins are grossly uninvolved. Cassettes submitted as follows. SURGICAL PATHOL Report. 1. Mass in relation to anterior and inferior margins (yellow-green). 2. Lateral (oranged) and medial (red margin). 3. Superior (blue) and deep (black margin). 4-8. Lesions submitted in toto. E. Received fresh and labeled "additional medial nodule, FS"consists of a segment of tan-yellow, fibro-adipose tissue, 2.3 x. 1.0 x 0.6 cm. The true margins inked black. Representative sections submitted as follows. 1. Sections submitted for frozen. 2. Reminder of specimen submitted in toto. ICD-9(s): 174.8.

expanded version (tokens=2306) : 
 The breast pathology report indicates the following:

1. Pathologic Interpretation: 
A. No carcinoma is found in any of the three sentinel lymph nodes examined
B. Right breast mass measuring 1.7 cm is identified as poorly differentiated ductal carcinoma (high nuclear grade) with 1.6 cm x 1.6 cm additional dimensions. 

2. Histological Classification:
a. Invasive ductal carcinoma subtype LumB, F.1
b. Histologic Grade: Nottingham Histologic Score 3 (3+3+2=8)
c. The tumor is single focus with central expansive comedo necrosis and tumor infiltrating lymphocytes
d. Lymphovascular invasion is present
e. Ductal carcinoma in situ (DCIS) is identified with the architectural patterns of cribriform/solid and nuclear grade III
f. Lobular carcinoma is absent

3. Receptor Status:
a. ER and PR are positive
b. HER-2 CISH is pending
c. HER-2 IHC is negative

4. Margins:
a. Margins uninvolved by invasive carcinoma
b. Margins uninvolved by DCIS with the closest margin measuring 5 mm (anterior)

5. Lymph Nodes:
a. Three sentinel lymph nodes were examined with no evidence of malignancy
b. The method of evaluation was Hematoxylin and eosin (H&E) and one level/immunoh

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2462) : 
 The right breast mass (1.7 cm) is identified as LumB, F.1 invasive ductal carcinoma subtype with central comedo necrosis and tumor infiltrating lymphocytes. ER and PR are positive, while HER2 CISH is pending and IHC is negative. The Nottingham Histologic Score is 3, with lymphovascular invasion present. Margins are uninvolved by invasive carcinoma with DCIS detected at a 5mm anterior margin. No malignancy was found in any of the three examined sentinel lymph nodes.

